CTRI/2020/10/028763进行中（未招募）未知
Assessment of serum tumor markers in response to neoadjuvant chemotherapy in locally advanced triple negative breast cancer
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
- AIIMS
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •All patients with a diagnosis of locally advanced triple negative breast cancer IRCH
排除标准
- •Not giving informed consent
研究者
相似试验
招募中
不适用
Clinical study on serum biomarkers associated with prognosis and pathology of POEMS syndromePOEMS syndromeJPRN-UMIN000044082Department of Neurology, Graduate School of Medicine, Chiba University100
尚未招募
不适用
Markers in abdominal traumaCTRI/2021/04/032510Department of general surgery IMS BH
招募中
2 期
Examination of the usefulness as the tumor marker of the NY-ESO-1 antibody titer in the esophageal cancer patientesophageal cancerJPRN-UMIN000008997Osaka University,Graduate School of Medicine, Department of Gastroenterological Surgery400
招募中
2 期
Examination of the usefulness as the tumor marker of the NY-ESO-1 antibody titer in the stomach cancer patientgastric cancerJPRN-UMIN000007925Osaka University Clinical Research Group for Gastroenterological Study1,000
已完成
不适用
CA209-759: Blood-borne biomarkers for tumor response to Nivolumab in KRAS-mutated non-small cell lung cancer, an exploratory studyNon-small cell lung cancer (NSCLC)10038666NL-OMON45880niversitair Medisch Centrum Groningen40